SECUADO
"SECUADO" is a word mark owned by Hisamitsu Pharmaceutical Co., Inc., filed at the CIPO on July 25, 2018. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since July 7, 2021
- Filed
- July 25, 2018
- Registered
- July 7, 2021
- Expires
- July 7, 2031
- Application no.
- 1911557
- Registration no.
- TMA1103441
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 1 class
Who owns SECUADO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Hisamitsu Pharmaceutical Co., Inc.
Japan
Representative
Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
What the mark covers
The products and services SECUADO is filed for, grouped by Nice class.
Medicated transdermal patches, plasters, cataplasms, gels, creams and sprays for the relief of aches and pains of muscles and joints associated with arthritis, simple backaches, strains, bruises and sprains; antiinflammatory and analgesic agents; Gauze for dressings; Capsules sold empty for pharmaceuticals; Eyepatches for medical purposes; Ear bandages; Menstruation bandages; Menstruation tampons; Sanitary napkins; Absorbent cotton; Cotton wool for medical purposes; Adhesive plasters, namely, adhesive bandages, surgical adhesives, medical plasters; Bandages for dressings; Liquid dressings, namely, burn dressings, medical and surgical dressings, self-adhesive dressings, wadding for wound dressing, wound dressings; Breast-nursing pads, breast-nursing padding, breast pads, breast shields; Wound dressings; Diapers, namely baby diapers, incontinence diapers, cloth diapers, disposable diapers; Dietary supplements for humans, namely, dietary supplements for general health and well-being; Dietetic beverages adapted for medical purposes, namely, herbal beverages for medicinal purposes, namely energy drinks for general health and well-being; Pharmaceutical preparations, namely, antihistamines and decongestants; Pharmaceutical antipsychotic preparations; Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, Parkinson's disease, and schizophrenia; pharmaceutical preparations for the treatment of schizophrenia.
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Registration Fee Notice Sent
- Registration Pending
- Advertised; Vol.68 Issue 3462
- Approval Notice Sent; APPROVED BY PROGRAM EX200M1
- Approved; APPROVED BY PROGRAM EX200M1
- Examiner's First Report
- Search Recorded
- Formalized
- Created
1 earlier step on the official record.
About SECUADO
Who owns the trademark "SECUADO"?
The CIPO trademark "SECUADO" (application 1911557) is owned by Hisamitsu Pharmaceutical Co., Inc.
What is the status of "SECUADO"?
Its status at the CIPO is: registered.
When was "SECUADO" registered?
It was registered on July 7, 2021 and is due to expire on July 7, 2031.
Get this data via the API
Everything on this page comes from the Signa API. Pull SECUADO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deaf4-8afc-70d4-8730-205895150a3d
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deaf4-8afc-70d4-8730-205895150a3d",
"object": "trademark",
"mark_text": "SECUADO",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "1911557",
"filing_date": "2018-07-25",
"nice_classes": [
5
],
"owners": [
{
"name": "Hisamitsu Pharmaceutical Co., Inc.",
"entity_id": "ent_019eb6f6-ad2b-709d-bc8b-1e01a4e6a66f"
}
]
}